Delivery Order SPE2DR25D1017-SPE2DR26F9CVF
Award Date 1/8/26
Potential Completion Date 1/9/26
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 200 mg, a nonsteroidal anti-inflammatory medication, valued at $1,031.41. The award, issued on October 31, 2025, with an ultimate completion date of November 3, 2025, utilized firm fixed price pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division as part of its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Celecoxib 200 mg capsules (500-count units) with a ceiling value of $1,557.18. This firm fixed-price delivery order, which is expected to be completed by August 15, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Celecoxib is a nonsteroidal anti-inflammatory drug commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 200 mg under a firm fixed-price contract valued at $20,551.98. The award, made on September 24, 2025, represents a non-competitive delivery order with an ultimate completion date of September 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,449.02 to AmerisourceBergen Drug Corp for 100 capsules of Celecoxib 200 mg, a nonsteroidal anti-inflammatory medication. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by September 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,597.37 firm fixed-price delivery order is for the supply of Celecoxib 200 mg capsules, a medication used to treat pain and inflammation. The contract has an ultimate completion date of August 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Celecoxib 200 mg capsules (500-count units) valued at $1,575.46. This is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,357.88 to AmerisourceBergen Drug Corp for the supply of Celebrex 200 mg capsules (unit dose, 100 count) on December 11, 2025, with an ultimate completion date of December 12, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Celebrex 200 mg capsule in unit dose packaging (100 count) under a firm fixed-price contract valued at $4,985.13. The award was made on December 17, 2025, with an ultimate completion date of December 18, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global...
- The Defense Logistics Agency awarded a $45,820 delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib 200 mg. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The firm fixed price order has a period of performance from August 17 to...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $3,786.34 for 100 capsules of Celebrex 200 mg on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Celebrex is a nonsteroidal anti-inflammatory drug commonly used for pain management and...